Calaspargase Pegol-mknl

Category: Cancer

Calaspargase Pegol-mknl Overview

Calaspargase pegol-mknl (trade name Asparlas) is a drug for the treatment of acute lymphoblastic leukemia (ALL). It is approved by the Food and Drug Administration for use in the United States as a component of a multi-agent chemotherapeutic regimen for ALL in pediatric and young adult patients aged 1 month to 21 years.[1] Calaspargase pegol is an engineered protein consisting of the E. coli-derived enzyme L-asparaginase II conjugated with succinimidyl carbonate monomethoxypo...

Read more Calaspargase Pegol-mknl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calaspargase_pegol-mknl

Recent Calaspargase Pegol-mknl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Calaspargase Pegol-mknl

Injection: 3750units/5ml

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Calaspargase Pegol-mknl or a similar ingredient: (1 result)

ASPARLAS Calaspargase Pegol-mknl